In case anyone is wondering how long it may take b
Post# of 1023
(Repost of joey68 DD)
It's important to be practical. First off, a run may never occur. As much as we want them to succeed, the company could fail just as easily as it could bring in revenue. Being invested doesn't equate to success.
Although I don't believe SCIE will fail, I try to think rationally with my investments. I don't have a need for 50 million shares in any one company, and I never fall for the 'buy more while you still can' fluff.
I'd rather have 1 million shares in 10 companies, therefor increasing my chance of success, than have 10 million shares in one company and watch that one fail.
The link below is a comparative study between SCIE and AVX$. Remember, comparing two companies does not mean in any way that they will react the same. The reason I chose to mention AVX$ was because it showed similar attributes to what SCIE is showing right now.
http://i.imgur.com/ot9mQOi.jpg
As you can see, the chart for AVX$ is displayed as it would look prior to the 1 for 4 reverse split which occurred Oct 7, 2015.
Notice how the PPS flatlined for well over a year. During this time, no investor knew what was going to happen. Many investors sold at a loss because nothing was happening for so long. Nay-sayers were 'winning' the online forum war by constantly bombarding investors with doom and gloom posts.
and yet, notice how, even prior to the RS, it went from .27 cents to $1.94 in less than 6 months. Following this, the PPS increased after the RS and skyrocketed to almost $15 in less than a month.
Notice the similarities in volume between AVX$ and SCIE. for years AVX$ had almost no volume and then volume started showing up out of nowhere; exactly like SCIE is doing right now.
Remember, I am not saying that what happened with AVX$ will happen to SCIE. Im simply saying that if SCIE does have a run, it could take some time before it actually happens. Im also saying that the chart is lining up for a run. Again, the big questions is, 'how long will the chart remain flatlined prior to this run?'
In the meantime, if I had to draw any conclusions, and I could be completely wrong, I believe the upcoming 10-K will show sales. I also know that SCIE has debt which needs to be taken care of, and hopefully these sales will assist in that. I think after the 10-K, we might see a PPS of around .002 but that's pure speculation.
What I do know is that if you look at the bolinger bands on a year chart, the bands were very far apart (high volatility), and now they are very close together (low volatility). Typically, high periods follow periods of low volatility which means that we should see some form of action this year. Of course, it all depends on the company and what the 10-K and the next 10-Qs say.
Think about..
1. Did we have sales?
2. We know SCIE has ongoing studies right now:
http://clinicaltrials.gov/ct2/show/NCT01980134
We know these studies were verified April 2014 by SpectraScience, which is almost 2 years ago, which means we should get results of some sort shortly.
In fact, and this just popped into my head, that last PR which mentioned results of the study by Dr. Helmut Neumann will be published in Endoscopy magazine. I wonder, is it possible the results are from these studies?? Maybe, maybe not; time will tell.
3. We know the study was published (last PR said so), so we have that to look forward to.
4. We know 5+ countries have the WavSTAT4 in their hospitals and are using it as we speak.
The 'knowns' in my opinion outweigh the 'unknowns'. We know a lot, we just have to wait for the PRs and SEC filings to tell us the other stuff.
(3) (0)